NCT01393249|Completed
PEG-Asparaginase Associated Pancreatitis, Hepatotoxicity and Hyperlipidemia in Children With ALL
AAP2008
Loading search results
AAP2008
Sponsor study identifier
Secondary identifiers
REGISTRY · VEK RegionH
observational
31
1 country
1
Study Start
July 2011
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
December 2013
Actual (reported)Study Completion
June 2014
Actual (reported)The purpose of this study is to create a model enabling us to predict pancreatitis, hyperlipidemia and hepatotoxicity during treatment with PEG-Asparaginase in children with Acute Lymphoblastic Leukemia.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 2014
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 2011
Date type not reportedThis date has not been verified as actual or estimated.
July 12, 2011
Actual (reported)July 13, 2011
Actual (reported)December 2013
Actual (reported)June 2014
Actual (reported)Risk of pancreatitis
Risk of pancreatitis in relation to host genomic variants, inflammatory markers and ultrasound changes in the weeks prior to clinical pancreatitia
During asparaginase therapy
Course of pancreatitis
In the months following pancreatitis
Patients that have been scanned and have had blood tests
Children aged 1-17.9, diagnosed with ALL and undergoing treatment with Peg-Asparaginase.
Rigshospitalet
Copenhagen, 2100, Denmark
Kjeld Schmiegelow, M.D.
Copenhagen University Hospital, Rigshospitalet
31 participants (actual enrollment reported by the registry).
First Submitted
July 12, 2011
First Posted
July 13, 2011
Study Start
July 2011
Date type not reportedThis date has not been verified as actual or estimated.
Second Malignant Neoplasms After Childhood ALL Therapy
Forecasting Hypersensitivity Against PEG-asparaginase to Optimize Outcome in ALL
Contact the study team to confirm eligibility.
Primary Completion
December 2013
Actual (reported)Study Completion
June 2014
Actual (reported)Last Updated
December 9, 2016
Record last verified: 2016-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: